Researchers in Germany have developed a new test process — using lab-on-a-chip technology — for establishing whether or not a cancer patient’s tumor cells will respond to a particular drug. Such sensor biochips could potentially be used in the future to aid in rapid identification of the most effective medication for individual patients.